Ask AI

Downloadable Webinar Slides

Share

Program Content

Activities

  • Menin Inhibitors in AML
    A New Revolution in AML Treatment: Can Menin Inhibitors Follow the Path of FLT3 and IDH Inhibitors?
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 22, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

Supported by educational grants from Johnson & Johnson, Kura Oncology, Inc. and Syndax Pharmaceuticals, Inc. 

Johnson & Johnson

Kura Oncology, Inc.

Syndax Pharmaceuticals, Inc.